Table of Contents

  • Gareth Morgan, M.D., Ph.D

From the Director

Dear Readers, Quality of life for patients is a top priority at the Myeloma Institute.  Our team is committed to providing a comprehensive, holistic experience, including effective disease management and emotional support for patients, family [...]

  • Donghoon Yoon, Ph.D., in his lab where his focus is on the factors and mechanisms of bone metabolism in myeloma

Bone Disease in Myeloma

Donghoon Yoon, Ph.D., in his lab where his focus is on the factors and mechanisms of bone metabolism in myeloma Bone disease is a hallmark of myeloma, affecting up to 90 percent of patients. An [...]

  • Carolina Schinke, M.D., assistant professor, conducts research that leads to development of new clinical trials.

Bone Remodeling Clinical Trial Assessment

Carolina Schinke, M.D., assistant professor, conducts research that leads to development of new clinical trials. Bone disease is a major issue for the majority of multiple myeloma patients.  Lytic lesions, fractures and collapse of vertebra [...]

  • Bobbie Rainey receiving a post-surgery exam by orthopaedic surgeon Corey Montgomery, M.D.

Partners in Care

Bobbie Rainey receiving a post-surgery exam by orthopaedic surgeon Corey Montgomery, M.D. Bobbie Rainey from Gould, Arkansas, came to the Myeloma Institute in September of 2010.  She was experiencing pain all over her body, especially [...]

  • Myeloma Cell

Plasma Cell Neoplasm — A Brief Primer

While multiple myeloma is the primary disease treated at the Myeloma Institute, other plasma cell neoplasms are also the focus of our research and treatment regimens. What is a Plasma Cell Neoplasm? A neoplasm is [...]

publications

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker A new publication in Blood Cancer Journal 24 February 2017, PMID: 28234347 Primary Authors: Shweta Chavan, Ph.D., and [...]

  • Giving Back

Giving Back and Creating a Legacy

The Myeloma Institute is a trailblazer in the development of innovative treatments for myeloma and other plasma cell neoplasms. With a firm commitment to helping patients regain their lives and look forward to a disease-free [...]

  • U.S. Ambassador Ruth A. Davis

Exceeding Expectations

Ambassador Ruth A. Davis traveled the world as a diplomat during her 40 years with the U.S. Foreign Service. But when she learned she had a relapse of multiple myeloma, she headed to Arkansas and [...]

  • Finding the Way

Finding the Way

How do new patients find their way to the Myeloma Institute? Often through a family physician or local oncologist or through a lot of online research. Sometimes the path is a bit circuitous. That was [...]